Cargando…

Rationale and Design of the STOP-OB Study for Evaluating the Effects of Tofogliflozin and Glimepiride on Fat Deposition in Type 2 Diabetes Patients Treated with Metformin/DPP-4 Inhibitor Dual Therapy

BACKGROUND: The global pandemic of type 2 diabetes mellitus (T2DM) is an enormous clinical and socioeconomic burden. Biguanides and DPP-4 inhibitors (DPP-4i) are the most commonly used therapies in Japanese T2DM patients. When glycemic control is not adequate despite combination of these drugs, ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishihara, Hisamitsu, Anai, Motonobu, Seino, Hiroaki, Kitazawa, Toru, Ohashi, Hiroshi, Ai, Masumi, Inoue, Masahiro, Fujishiro, Midori, Inazawa, Takeshi, Kuroda, Hisamoto, Yamada, Masayo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167289/ https://www.ncbi.nlm.nih.gov/pubmed/30145651 http://dx.doi.org/10.1007/s13300-018-0491-4

Ejemplares similares

Comparison of tofogliflozin versus glimepiride as the third oral agent added to metformin plus a dipeptidyl peptidase‐4 inhibitor in Japanese patients with type 2 diabetes: A randomized, 24‐week, open‐label, controlled trial (STOP‐OB)
por: Kitazawa, Toru, et al.
Publicado: (2020)

The DPP-4 Inhibitor Linagliptin Counteracts Stroke in the Normal and Diabetic Mouse Brain: A Comparison With Glimepiride
por: Darsalia, Vladimer, et al.
Publicado: (2013)

Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial
por: Takeshita, Yumie, et al.
Publicado: (2022)

Comparison of Combined Tofogliflozin and Glargine, Tofogliflozin Added to Insulin, and Insulin Dose-Increase Therapy in Uncontrolled Type 2 Diabetes
por: Suzuki, Katsunori, et al.
Publicado: (2016)

Acute esophageal necrosis after cellulitis in an obese patient with diabetes mellitus
por: Tanaka, Sho, et al.
Publicado: (2019)

Impact of Female Sex on the Susceptibility to Hypernatremia Among Older Community-Dwelling Individuals in Japan
por: Tanaka, Sho, et al.
Publicado: (2022)

Selective PPARα Modulator Pemafibrate and Sodium-Glucose Cotransporter 2 Inhibitor Tofogliflozin Combination Treatment Improved Histopathology in Experimental Mice Model of Non-Alcoholic Steatohepatitis
por: Murakami, Kentaro, et al.
Publicado: (2022)

A large-scale functional analysis of genes expressed differentially in insulin secreting MIN6 sublines with high versus mildly reduced glucose-responsiveness
por: Tanaka, Aya, et al.
Publicado: (2023)

Comparative safety for cardiovascular outcomes of DPP-4 inhibitors versus glimepiride in patients with type 2 diabetes: A retrospective cohort study
por: Chin, Hyouk-Jun, et al.
Publicado: (2017)

Association of Glycated Hemoglobin Level with Self-Reported Chewing Problems in Elderly Community-Dwelling Individuals in Japan
por: Fujishiro, Midori, et al.
Publicado: (2023)

Effects of Tofogliflozin on Cardiac Function in Elderly Patients With Diabetes Mellitus
por: Higashikawa, Toshihiro, et al.
Publicado: (2020)

Effectiveness and safety of glimepiride and iDPP4, associated with metformin in second line pharmacotherapy of type 2 diabetes mellitus: systematic review and meta‐analysis
por: Amate, JM., et al.
Publicado: (2015)

Severe Hypertriglyceridemia Possibly Masked Acute Pancreatitis and Led to a Difficult Diagnosis in an Obese Patient with Ketoacidosis-onset Type 2 Diabetes
por: Fujishiro, Midori, et al.
Publicado: (2017)

Effect of Adult Weight Gain on Non-Alcoholic Fatty Liver Disease and Its Association with Anthropometric Parameters in the Lean Japanese Population
por: Tanaka, Sho, et al.
Publicado: (2020)

Tofogliflozin decreases body fat mass and improves peripheral insulin resistance
por: Matsuba, Ren, et al.
Publicado: (2018)

Is there a distinct phenotype of diabetic patients who benefit from tofogliflozin?
por: Patoulias, Dimitrios Ioannis
Publicado: (2018)

Treatment Burden on Once-Weekly Omarigliptin Versus Daily Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes: Randomized Controlled Trial (ONWARD-DPP4 Study)
por: Ishii, Hitoshi, et al.
Publicado: (2023)

Abdominal Irradiation Ameliorates Obesity in ob/ob Mice
por: Okada, Sumiyo, et al.
Publicado: (2007)

The Physiology of Obese-Hyperglycemic Mice [ob/ob Mice]
por: Lindström, Per
Publicado: (2007)

Formulation and characterization of orodispersible tablet of glimepiride
por: Kinani, Ahmad AB Yosef, et al.
Publicado: (2022)

A Single Episode of Hypoglycemia as a Possible Early Warning Sign of Adrenal Insufficiency
por: Tanaka, Sho, et al.
Publicado: (2020)

Hyponatremia Associated with Prophylactic Low-Dose Trimethoprim during Systemic Corticosteroid Therapy for AQP4-Positive Optic Neuritis in a Diabetic Patient
por: Takubo, Masahiro, et al.
Publicado: (2020)

Peripheral nervous system insulin resistance in ob/ob mice
por: Grote, Caleb W, et al.
Publicado: (2013)

Sirtuin-2 Regulates Sepsis Inflammation in ob/ob Mice
por: Wang, Xianfeng, et al.
Publicado: (2016)

Impaired Muscle Regeneration in Ob/ob and Db/db Mice
por: Nguyen, Mai-Huong, et al.
Publicado: (2011)

Energy homeostasis in leptin deficient Lep(ob/ob) mice
por: Skowronski, Alicja A., et al.
Publicado: (2017)

Maintenance of Obesity Following Hypophysectomy in the Obese Hyperglycemic Mouse (ob/ob)
por: Plocher, Thomas A., et al.
Publicado: (1977)

Correction: Sirtuin-2 Regulates Sepsis Inflammation in ob/ob Mice
por: Wang, Xianfeng, et al.
Publicado: (2016)

Gut Microbiota Composition and Structure of the Ob/Ob and Db/Db Mice
por: Yang, Mingsheng, et al.
Publicado: (2019)

Induction of obesity impairs reverse cholesterol transport in ob/ob mice
por: Duong, MyNgan, et al.
Publicado: (2018)

Leptin Increases Particle-Induced Osteolysis in Female ob/obMice
por: Philbrick, Kenneth A., et al.
Publicado: (2018)

ObsPlus: A Pandas-centric ObsPy expansion pack
por: Chambers, Derrick J.A., et al.
Publicado: (2021)

Glimepiride: evidence-based facts, trends, and observations
por: Basit, Abdul, et al.
Publicado: (2012)

Formulation and Evaluation of New Glimepiride Sublingual Tablets
por: Al-Madhagi, Wafa, et al.
Publicado: (2017)

Erratum: Formulation and characterization of orodispersible tablet of glimepiride
Publicado: (2023)

High-fat diet feeding significantly attenuates anagliptin-induced regeneration of islets of Langerhans in streptozotocin-induced diabetic mice
por: Shinjo, Takanori, et al.
Publicado: (2015)

Inverse Correlation Between Grip Strength and Serum Phosphorus: A Retrospective Observational Study in Japanese Elderly with Poorly Controlled Type 2 Diabetes
por: Tanaka, Sho, et al.
Publicado: (2020)

Comparison of the efficacy of sitagliptin and glimepiride dose‐up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination
por: Shimoda, Seiya, et al.
Publicado: (2013)

The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus
por: Katakami, Naoto, et al.
Publicado: (2021)

Combination of tofogliflozin and pioglitazone for NAFLD: Extension to the ToPiND randomized controlled trial
por: Yoneda, Masato, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3ok7ostdt1cldh6hstfe6ta2du